1-Azetidineethanamine - CAS 795299-77-3
Catalog: |
BB061527 |
Product Name: |
1-Azetidineethanamine |
CAS: |
795299-77-3 |
Synonyms: |
2-(azetidin-1-yl)ethan-1-amine; 2-(azetidin-1-yl)ethanamine; 1-Azetidineethanamine; 1-(2-Aminoethyl)azetidine; N-aminoethyl azetidine; N-(2-aminoethyl)azetidine; 2-(1-Azetidinyl)ethanamine |
IUPAC Name: | 2-(azetidin-1-yl)ethanamine |
Molecular Weight: | 100.16 |
Molecular Formula: | C5H12N2 |
Canonical SMILES: | C1CN(C1)CCN |
InChI: | InChI=1S/C5H12N2/c6-2-5-7-3-1-4-7/h1-6H2 |
InChI Key: | RIHYLJLIMZMKTQ-UHFFFAOYSA-N |
GHS Hazard Statement: | H226 (100%): Flammable liquid and vapor [Warning Flammable liquids] |
Precautionary Statement: | P210, P233, P240, P241, P242, P243, P264, P264+P265, P270, P280, P301+P317, P303+P361+P353, P305+P354+P338, P317, P330, P370+P378, P403+P235, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021202775-A1 | N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as sstr4 agonists | 20200331 |
WO-2021173593-A1 | Indole compounds for the treatment of neurodegenerative diseases | 20200224 |
WO-2021127499-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20191218 |
US-10851073-B2 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
US-2020299246-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
WO-2020186199-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
AU-2020234712-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
CN-114025844-A | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
EP-3938038-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
IL-286373-D0 | Protein Tyrosine Protein Suppressant Compounds and their Uses | 20190314 |
PMID | Publication Date | Title | Journal |
5234 | 19760101 | Transition of properties in the silk gland trehalase during metamorphosis of the silkworm, Bombyx mori | Comparative biochemistry and physiology. B, Comparative biochemistry |
Complexity: | 50 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 100.100048391 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 100.100048391 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 29.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS